Claims for Patent: 11,464,743

Summary for Patent: 11,464,743

Title:	Gate for a tablet discharge of a tablet press and method for actuating a gate
Abstract:	A tablet press comprises a gate that defines a first switching position that feeds tablets into a first tablet outlet and at least a second switching position that feeds tablets into at least one second tablet outlet. The table press further comprises a control apparatus and a drive apparatus. The drive apparatus is configured to be actuated by the control apparatus to move the gate from a home position defined as one of the first switching position and the at least a second switching position into a target position defined as a switching position that is not the home position. The gate is moved from the home switching position at a speed of movement toward the target position such that the speed of movement of the gate is reduced before the target position is reached.
Inventor(s):	Friedrich Meissner, Stefan Luedemann
Assignee:	Fette Compacting GmbH
Application Number:	US16/458,621

Details for Patent 11,464,743

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Seres Therapeutics, Inc.	VOWST	fecal microbiota spores	Capsule	125757	April 26, 2023	11,464,743	2039-07-01
Janssen Biotech, Inc.	STELARA	ustekinumab	Injection	761044	September 23, 2016	11,464,743	2039-07-01

International Patent Family for US Patent 11,464,743

Country	Patent Number	Estimated Expiration
United States of America	2020009057
Poland	3590871
Japan	7033106
Japan	2020006439
European Patent Office	3590871
Germany	102018116143